51 related articles for article (PubMed ID: 16239602)
1. Mutation P732L in human DNA topoisomerase IIbeta abolishes DNA cleavage in the presence of calcium and confers drug resistance.
Leontiou C; Lakey JH; Lightowlers R; Turnbull RM; Austin CA
Mol Pharmacol; 2006 Jan; 69(1):130-9. PubMed ID: 16239602
[TBL] [Abstract][Full Text] [Related]
2. The geometry of DNA supercoils modulates topoisomerase-mediated DNA cleavage and enzyme response to anticancer drugs.
McClendon AK; Osheroff N
Biochemistry; 2006 Mar; 45(9):3040-50. PubMed ID: 16503659
[TBL] [Abstract][Full Text] [Related]
3. Bimodal recognition of DNA geometry by human topoisomerase II alpha: preferential relaxation of positively supercoiled DNA requires elements in the C-terminal domain.
McClendon AK; Gentry AC; Dickey JS; Brinch M; Bendsen S; Andersen AH; Osheroff N
Biochemistry; 2008 Dec; 47(50):13169-78. PubMed ID: 19053267
[TBL] [Abstract][Full Text] [Related]
4. Use of CRISPR/Cas9 with Homology-Directed Repair to Gene-Edit Topoisomerase II
Carvajal-Moreno J; Wang X; Hernandez VA; Mondal M; Zhao X; Yalowich JC; Elton TS
J Pharmacol Exp Ther; 2024 Apr; 389(2):186-196. PubMed ID: 38508753
[TBL] [Abstract][Full Text] [Related]
5. The alpha4 residues of human DNA topoisomerase IIalpha function in enzymatic activity and anticancer drug sensitivity.
Suda N; Ito Y; Imai T; Kikumori T; Kikuchi A; Nishiyama Y; Yoshida S; Suzuki M
Nucleic Acids Res; 2004; 32(5):1767-73. PubMed ID: 15026536
[TBL] [Abstract][Full Text] [Related]
6. Basis for the discrimination of supercoil handedness during DNA cleavage by human and bacterial type II topoisomerases.
Jian JY; McCarty KD; Byl JAW; Guengerich FP; Neuman KC; Osheroff N
Nucleic Acids Res; 2023 May; 51(8):3888-3902. PubMed ID: 36999602
[TBL] [Abstract][Full Text] [Related]
7. Recurrent mutations in topoisomerase IIα cause a previously undescribed mutator phenotype in human cancers.
Boot A; Liu M; Stantial N; Shah V; Yu W; Nitiss KC; Nitiss JL; Jinks-Robertson S; Rozen SG
Proc Natl Acad Sci U S A; 2022 Jan; 119(4):. PubMed ID: 35058360
[TBL] [Abstract][Full Text] [Related]
8. Calcineurin dephosphorylates topoisomerase IIβ and regulates the formation of neuronal-activity-induced DNA breaks.
Delint-Ramirez I; Konada L; Heady L; Rueda R; Jacome ASV; Marlin E; Marchioni C; Segev A; Kritskiy O; Yamakawa S; Reiter AH; Tsai LH; Madabhushi R
Mol Cell; 2022 Oct; 82(20):3794-3809.e8. PubMed ID: 36206766
[TBL] [Abstract][Full Text] [Related]
9. Targeting TOP2B as a vulnerability in aging and aging-related diseases.
Zhu M; Li H; Zheng Y; Yang J
Biochim Biophys Acta Mol Basis Dis; 2024 Mar; 1870(3):167044. PubMed ID: 38296114
[TBL] [Abstract][Full Text] [Related]
10. Integrative analysis of multi-omics data reveals inhibition of RB1 signaling promotes apatinib resistance of hepatocellular carcinoma.
He K; An S; Liu F; Chen Y; Xiang G; Wang H
Int J Biol Sci; 2023; 19(14):4511-4524. PubMed ID: 37781033
[TBL] [Abstract][Full Text] [Related]
11. Evolutionary History of TOPIIA Topoisomerases in Animals.
Moreira F; Arenas M; Videira A; Pereira F
J Mol Evol; 2022 Apr; 90(2):149-165. PubMed ID: 35165762
[TBL] [Abstract][Full Text] [Related]
12. A complex suite of loci and elements in eukaryotic type II topoisomerases determine selective sensitivity to distinct poisoning agents.
Blower TR; Bandak A; Lee ASY; Austin CA; Nitiss JL; Berger JM
Nucleic Acids Res; 2019 Sep; 47(15):8163-8179. PubMed ID: 31287876
[TBL] [Abstract][Full Text] [Related]
13. TOP2B: The First Thirty Years.
Austin CA; Lee KC; Swan RL; Khazeem MM; Manville CM; Cridland P; Treumann A; Porter A; Morris NJ; Cowell IG
Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30223465
[TBL] [Abstract][Full Text] [Related]
14. Calcium-driven DNA synthesis by a high-fidelity DNA polymerase.
Ralec C; Henry E; Lemor M; Killelea T; Henneke G
Nucleic Acids Res; 2017 Dec; 45(21):12425-12440. PubMed ID: 29040737
[TBL] [Abstract][Full Text] [Related]
15. Fluoroquinolones stimulate the DNA cleavage activity of topoisomerase IV by promoting the binding of Mg(2+) to the second metal binding site.
Oppegard LM; Schwanz HA; Towle TR; Kerns RJ; Hiasa H
Biochim Biophys Acta; 2016 Mar; 1860(3):569-75. PubMed ID: 26723176
[TBL] [Abstract][Full Text] [Related]
16. The impact of the C-terminal domain on the interaction of human DNA topoisomerase II α and β with DNA.
Gilroy KL; Austin CA
PLoS One; 2011 Feb; 6(2):e14693. PubMed ID: 21358820
[TBL] [Abstract][Full Text] [Related]
17. Use of divalent metal ions in the DNA cleavage reaction of topoisomerase IV.
Pitts SL; Liou GF; Mitchenall LA; Burgin AB; Maxwell A; Neuman KC; Osheroff N
Nucleic Acids Res; 2011 Jun; 39(11):4808-17. PubMed ID: 21300644
[TBL] [Abstract][Full Text] [Related]
18. The use of divalent metal ions by type II topoisomerases.
Deweese JE; Osheroff N
Metallomics; 2010 Jul; 2(7):450-9. PubMed ID: 20703329
[TBL] [Abstract][Full Text] [Related]
19. Metal ion interactions in the DNA cleavage/ligation active site of human topoisomerase IIalpha.
Deweese JE; Guengerich FP; Burgin AB; Osheroff N
Biochemistry; 2009 Sep; 48(38):8940-7. PubMed ID: 19697956
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
